APAnjasu Paul

Anjasu Paul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anjasu Paul has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular determinants of antimicrobial resistance in Klebsiella pneumoniae isolates among geriatric patients in Chattogram, Bangladesh: a cross-sectional study

    by Mahmud Hassan Arif, Afroza Akter Tanni, Farhana Yasmin, Mirza Nurul Karim, Enshad Ekram Ullah, Md. Abdus Sattar, Jannatul Ferdous, Nazia Farha, Anjasu Paul, Sadman Yousuf Sajid, et al.

    Klebsiella pneumoniae (KPN) infections pose heightened risks in the geriatric population due to weakened immunity, prevalent comorbidities, potential exposure in long-term care settings, and increased likelihood of antibiotic resistance (ABR). The study focused on the prevalence and antibiotic resistance of KPN infections, the presence of ABR genes in KPN, and the genomic characterization of KPN obtained from geriatric patients in Chattogram. A total of 543 specimens were collected from four hospitals in Chattogram, along with demographic data from hospital records. Genomic DNA was extracted from multi-drug-resistant (MDR) KPN, and the presence of ABR genes , bla TEM-1 , sul-1 , aadB , bla NDM-1 , bla SHV-11 , and phoE was identified. To characterize the KPN genomes, two MDR KPN isolates were subjected to whole-genome sequencing (WGS), and the data were analyzed using bioinformatics tools to identify genomic determinants of ABR. KPN exhibited high resistance to ceftazidime (96%), cefuroxime (92%), and cefixime (83%), but sensitivity to colistin (79%) and amikacin (75%). MDR KPN was mostly detected in sputum (36%) and urine (27%) specimens, where the prevalence of ABR genes, blaTEM-1 , sul1 , aadB , blaNDM-1 , and blaSHV-11 were 28.2%, 17%, 6.17%, 56%, and 48% of these strains, respectively. These genomes exhibited distinct profiles for sequence types, ST420 and ST277 in Kpn007 and Kpn016, respectively, and ABR genes ( qnrS1 , blaCTX-M-15 , and blaSHV-27 ), virulence factors ( ybt , iuc1 , iro1 ), and contained both K (K20, K46) and O antigens (O1, O3b). MDR KPN in the geriatric population poses a serious health concern due to their increased vulnerability to infections and limited treatment options, requiring careful management. IMPORTANCE: Multidrug resistance (MDR) and the hypervirulence nature of Klebsiella pneumoniae (KPN) in geriatric patients pose a critical health concern in nosocomial infections worldwide and result in high clinical complexity and mortality. The study investigated the factors for KPN infections and analyzed antimicrobial resistance profiles. More than 60% of Klebsiella pneumoniae isolates from geriatric patients were resistant to third- and fourth-generation cephalosporins, and most isolates carried bla NDM-1 and bla SHV-11 genes. Analyzing whole genomes of two KPNs, Kpn007 (ST277) was identified as a hypervirulent strain with aerobactin and yersinia siderophores, contributing to virulence, and Kpn016 (ST420) carried fluoroquinolone ( qnrS1 ), ESBL ( bla CTX-M-15 and bla SHV-27 ) resistance. Both genomes contained K antigens (K20 and K46) and O antigens (O1 and O3b).

  • Open Access

    Complete genome sequence of dengue virus serotype 2 obtained from Chattogram, Bangladesh

    by Mohabbat Hossain, Abdur Rob, M. A. Sattar, Abul Faisal Md. Nuruddin Chowdhury, Noor Mohammed, Istiaq Uddin Ahmed, Mohammed Maruf Ul Quader, H. M. Hamidullah Mehedi, Zakir Hossain, Mobarok Hossain, et al.

    The whole genome sequence of a dengue virus serotype 2 strain (GenBank accession number PQ657766 ) obtained from a dengue-infected hospitalized patient in Chittagong, Bangladesh, is classified as the cosmopolitan genotype V, with genetic alterations observed in several structural proteins. The genomic data were generated using Oxford Nanopore sequencing technology.

  • An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines

    by Anjasu Paul, Belayet Hasan Limon, Mobarok Hossain, Thosif Raza

    TBX3 is an ancient and evolutionarily conserved family member of T-box transcription factors that acts as a key regulator in embryonic development and organogenesis. It is often overexpressed in various epithelial and mesenchymal malignancies which has a significant impact on various hallmarks of cancer, which mainly includes senescence shunt, apoptosis, anoikis, angiogenesis, and promoting metastatic and expansion of cancer stem cells. In addition to the role of TBX3 in early breast development, a number of studies have also confirmed the amplification of TBX3 in the occurrence and development of breast cancer. To overcome a major challenge in breast cancer treatment, resistance to current anti-cancer drug, it is important to develop new drug pipeline. In this study of different alkaloid molecules, to identify potential alkaloid inhibitors of TBX3, a structure based virtual screening was done involving molecular docking, ADME, toxicity analysis, molecular dynamics simulation. From our study 5 ligands named Jervine, Diflomotecan, Camptothecin, Vincamine, and Anoniane were primarily confirmed as potential inhibitors. The followed screening manner funnels out five potential compounds that have a high scoring function that emphasizes their high binding ability along with no toxicity effects. The molecular mechanics-generalized born surface area (MM-GBSA) and molecular dynamics (MD) simulation showed that Jervine along with Diflomotecan formed the stable complexes with TBX3 which makes it obvious that these two alkaloids can be introduced into the drug development pipeline and used as a new leader to develop new effective drugs against breast cancer. Communicated by Ramaswamy H. Sarma